Charles Schwab Investment Management Inc Ultragenyx Pharmaceutical Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 484,381 shares of RARE stock, worth $21.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
484,381
Previous 471,825
2.66%
Holding current value
$21.9 Million
Previous $22.6 Million
0.23%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding RARE
# of Institutions
290Shares Held
78.6MCall Options Held
570KPut Options Held
228K-
Vanguard Group Inc Valley Forge, PA8.7MShares$393 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.09MShares$320 Million5.31% of portfolio
-
Black Rock Inc. New York, NY5.24MShares$237 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.1MShares$185 Million0.03% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.86MShares$174 Million0.53% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.16B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...